fulminant hepatitis
Image Gallery
[ (||image_reduire{0,60}|inserer_attribut{alt,Massive hepatic necrosis in fulminant auto-immune hepatitis}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Massive hepatic necrosis in fulminant auto-immune hepatitis}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Massive hepatic necrosis in fulminant auto-immune hepatitis}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Massive hepatic necrosis in fulminant auto-immune hepatitis}) ]Clinicobiological syndrome associated with hepatic insufficiency and massive hepatocytic necrosis.
Etiology
fulminant infectious hepatitis
- fulminant viral hepatitis (54.2%)
- fulminant virus A hepatitis
fulminant drug-induced hepatitis (14.2%)
- reversible valproate fulminant hepatic failure
- tolcapone-related fulminant hepatitis
- flutamide-associated acute liver failure
fulminant dysimmune hepatitis
- fulminant auto-immune hepatitis
metabolic fulminant hepatitis
- Wilson disease (11.4%)
- Reye syndrome
drug-induced fulminant hepatitis (drug-induced active liver failure)
Animal models
Fas-mediated fulminant hepatitis in mice (TNFRSF6)
See also
acute liver failure
massive hepatic necrosis